Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model

Gail D. Anderson, Todd C. Peterson, Cole Vonder Haar, Fred M. Farin, Theo K. Bammler, James W. MacDonald, Eric D. Kantor, Michael R. Hoane

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In contrast to considerable data demonstrating a decrease in cytochrome P450 (CYP) activity in inflammation and infection, clinically, traumatic brain injury (TBI) results in an increase in CYP and UDP glucuronosyltransferase (UGT) activity. The objective of this study was to determine the effects of TBI alone and with treatment with erythropoietin (EPO) or anakinra on the gene expression of hepatic inflammatory proteins, drug-metabolizing enzymes, and transporters in a cortical contusion impact (CCI) injury model. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24 h, 72 h, and 7 days post-CCI. Plasma cytokine and liver protein concentrations of CYP2D4, CYP3A1, EPHX1, and UGT2B7 were determined. There was no effect of TBI, TBI + EPO, or TBI + anakinra on gene expression of the inflammatory factors shown to be associated with decreased expression of hepatic metabolic enzymes in models of infection and inflammation. IL-6 plasma concentrations were increased in TBI animals and decreased with EPO and anakinra treatment. There was no significant effect of TBI and/or anakinra on gene expression of enzymes or transporters known to be involved in drug disposition. TBI + EPO treatment decreased the gene expression of Cyp2d4 at 72 h with a corresponding decrease in CYP2D4 protein at 72 h and 7 days. CYP3A1 protein was decreased at 24 h. In conclusion, EPO treatment may result in a significant decrease in the metabolism of Cyp-metabolized drugs. In contrast to clinical TBI, there was not a significant effect of experimental TBI on CYP or UGT metabolic enzymes.

Original languageEnglish (US)
Pages (from-to)1255-1267
Number of pages13
JournalAAPS Journal
Volume17
Issue number5
DOIs
StatePublished - Sep 21 2015
Externally publishedYes

Fingerprint

Interleukin 1 Receptor Antagonist Protein
Erythropoietin
Theoretical Models
Liver
Enzymes
Gene Expression
Cytochrome P-450 Enzyme System
Glucuronosyltransferase
Proteins
Traumatic Brain Injury
Pharmaceutical Preparations
Inflammation
Infection
Interleukin-6
Cytokines

Keywords

  • anakinra
  • erythropoietin
  • hepatic metabolism
  • traumatic brain injury

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model. / Anderson, Gail D.; Peterson, Todd C.; Vonder Haar, Cole; Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.; Kantor, Eric D.; Hoane, Michael R.

In: AAPS Journal, Vol. 17, No. 5, 21.09.2015, p. 1255-1267.

Research output: Contribution to journalArticle

Anderson, GD, Peterson, TC, Vonder Haar, C, Farin, FM, Bammler, TK, MacDonald, JW, Kantor, ED & Hoane, MR 2015, 'Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model', AAPS Journal, vol. 17, no. 5, pp. 1255-1267. https://doi.org/10.1208/s12248-015-9792-y
Anderson, Gail D. ; Peterson, Todd C. ; Vonder Haar, Cole ; Farin, Fred M. ; Bammler, Theo K. ; MacDonald, James W. ; Kantor, Eric D. ; Hoane, Michael R. / Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model. In: AAPS Journal. 2015 ; Vol. 17, No. 5. pp. 1255-1267.
@article{7fa574ec96934445b785ec2f289c30d1,
title = "Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model",
abstract = "In contrast to considerable data demonstrating a decrease in cytochrome P450 (CYP) activity in inflammation and infection, clinically, traumatic brain injury (TBI) results in an increase in CYP and UDP glucuronosyltransferase (UGT) activity. The objective of this study was to determine the effects of TBI alone and with treatment with erythropoietin (EPO) or anakinra on the gene expression of hepatic inflammatory proteins, drug-metabolizing enzymes, and transporters in a cortical contusion impact (CCI) injury model. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24 h, 72 h, and 7 days post-CCI. Plasma cytokine and liver protein concentrations of CYP2D4, CYP3A1, EPHX1, and UGT2B7 were determined. There was no effect of TBI, TBI + EPO, or TBI + anakinra on gene expression of the inflammatory factors shown to be associated with decreased expression of hepatic metabolic enzymes in models of infection and inflammation. IL-6 plasma concentrations were increased in TBI animals and decreased with EPO and anakinra treatment. There was no significant effect of TBI and/or anakinra on gene expression of enzymes or transporters known to be involved in drug disposition. TBI + EPO treatment decreased the gene expression of Cyp2d4 at 72 h with a corresponding decrease in CYP2D4 protein at 72 h and 7 days. CYP3A1 protein was decreased at 24 h. In conclusion, EPO treatment may result in a significant decrease in the metabolism of Cyp-metabolized drugs. In contrast to clinical TBI, there was not a significant effect of experimental TBI on CYP or UGT metabolic enzymes.",
keywords = "anakinra, erythropoietin, hepatic metabolism, traumatic brain injury",
author = "Anderson, {Gail D.} and Peterson, {Todd C.} and {Vonder Haar}, Cole and Farin, {Fred M.} and Bammler, {Theo K.} and MacDonald, {James W.} and Kantor, {Eric D.} and Hoane, {Michael R.}",
year = "2015",
month = "9",
day = "21",
doi = "10.1208/s12248-015-9792-y",
language = "English (US)",
volume = "17",
pages = "1255--1267",
journal = "AAPS Journal",
issn = "1550-7416",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model

AU - Anderson, Gail D.

AU - Peterson, Todd C.

AU - Vonder Haar, Cole

AU - Farin, Fred M.

AU - Bammler, Theo K.

AU - MacDonald, James W.

AU - Kantor, Eric D.

AU - Hoane, Michael R.

PY - 2015/9/21

Y1 - 2015/9/21

N2 - In contrast to considerable data demonstrating a decrease in cytochrome P450 (CYP) activity in inflammation and infection, clinically, traumatic brain injury (TBI) results in an increase in CYP and UDP glucuronosyltransferase (UGT) activity. The objective of this study was to determine the effects of TBI alone and with treatment with erythropoietin (EPO) or anakinra on the gene expression of hepatic inflammatory proteins, drug-metabolizing enzymes, and transporters in a cortical contusion impact (CCI) injury model. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24 h, 72 h, and 7 days post-CCI. Plasma cytokine and liver protein concentrations of CYP2D4, CYP3A1, EPHX1, and UGT2B7 were determined. There was no effect of TBI, TBI + EPO, or TBI + anakinra on gene expression of the inflammatory factors shown to be associated with decreased expression of hepatic metabolic enzymes in models of infection and inflammation. IL-6 plasma concentrations were increased in TBI animals and decreased with EPO and anakinra treatment. There was no significant effect of TBI and/or anakinra on gene expression of enzymes or transporters known to be involved in drug disposition. TBI + EPO treatment decreased the gene expression of Cyp2d4 at 72 h with a corresponding decrease in CYP2D4 protein at 72 h and 7 days. CYP3A1 protein was decreased at 24 h. In conclusion, EPO treatment may result in a significant decrease in the metabolism of Cyp-metabolized drugs. In contrast to clinical TBI, there was not a significant effect of experimental TBI on CYP or UGT metabolic enzymes.

AB - In contrast to considerable data demonstrating a decrease in cytochrome P450 (CYP) activity in inflammation and infection, clinically, traumatic brain injury (TBI) results in an increase in CYP and UDP glucuronosyltransferase (UGT) activity. The objective of this study was to determine the effects of TBI alone and with treatment with erythropoietin (EPO) or anakinra on the gene expression of hepatic inflammatory proteins, drug-metabolizing enzymes, and transporters in a cortical contusion impact (CCI) injury model. Microarray-based transcriptional profiling was used to determine the effect on gene expression at 24 h, 72 h, and 7 days post-CCI. Plasma cytokine and liver protein concentrations of CYP2D4, CYP3A1, EPHX1, and UGT2B7 were determined. There was no effect of TBI, TBI + EPO, or TBI + anakinra on gene expression of the inflammatory factors shown to be associated with decreased expression of hepatic metabolic enzymes in models of infection and inflammation. IL-6 plasma concentrations were increased in TBI animals and decreased with EPO and anakinra treatment. There was no significant effect of TBI and/or anakinra on gene expression of enzymes or transporters known to be involved in drug disposition. TBI + EPO treatment decreased the gene expression of Cyp2d4 at 72 h with a corresponding decrease in CYP2D4 protein at 72 h and 7 days. CYP3A1 protein was decreased at 24 h. In conclusion, EPO treatment may result in a significant decrease in the metabolism of Cyp-metabolized drugs. In contrast to clinical TBI, there was not a significant effect of experimental TBI on CYP or UGT metabolic enzymes.

KW - anakinra

KW - erythropoietin

KW - hepatic metabolism

KW - traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=84939565711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939565711&partnerID=8YFLogxK

U2 - 10.1208/s12248-015-9792-y

DO - 10.1208/s12248-015-9792-y

M3 - Article

VL - 17

SP - 1255

EP - 1267

JO - AAPS Journal

JF - AAPS Journal

SN - 1550-7416

IS - 5

ER -